Real-world data from Switzerland demonstrates high patient adherence to wearable cardioverter-defibrillators with treatment rates aligning with existing registry data.
The use of WCDs has increased in Switzerland over the years for a variety of indications. There is high therapy adherence to the WCD, and a treatment rate comparable to previously published registry data. .
Kovacs et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: